Related Experiment Video
Updated: Jul 3, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Should chlorthalidone be the diuretic of choice for antihypertensive therapy?
1Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. taler.sandra@mayo.edu
Insights
Chlorthalidone and hydrochlorothiazide are effective diuretic therapies for hypertension, reducing cardiovascular events. This review examines their comparative benefits and risks to guide treatment choices.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Background:
- Diuretic therapy is a primary treatment for hypertension, proven to reduce cardiovascular events.
- Controversy exists regarding the metabolic side effects of diuretics.
- The choice between thiazide and thiazidelike diuretics, specifically chlorthalidone and hydrochlorothiazide, remains debated.
Purpose of the Study:
- To review the evidence comparing chlorthalidone and hydrochlorothiazide for hypertension management.
- To analyze the cardiovascular benefits, metabolic effects, and side effect profiles of each agent.
- To provide recommendations for optimal thiazide or thiazidelike diuretic selection.
Main Methods:
- Systematic review of randomized controlled trials and observational studies.
- Analysis of data on cardiovascular outcomes, metabolic parameters, and adverse events.
- Comparative assessment of chlorthalidone and hydrochlorothiazide efficacy and safety.
Main Results:
- Chlorthalidone has demonstrated significant reductions in cardiovascular events in classic trials, attributed partly to its longer half-life.
- Hydrochlorothiazide-based therapy shows comparable favorable results, with wider availability in low-dose formulations.
- Both agents have potential metabolic side effects that require monitoring.
Conclusions:
- The choice between chlorthalidone and hydrochlorothiazide involves weighing demonstrated long-term cardiovascular benefits against factors like dosing availability and side effect profiles.
- Further research may clarify optimal patient selection for each diuretic agent.
- Evidence supports the continued use of thiazide and thiazidelike diuretics in hypertension management.
Abstract:
For decades, diuretic therapy has been a cornerstone in treating hypertension, an approach supported by multiple randomized controlled trials demonstrating reduced morbidity and mortality from cardiovascular events. Yet controversy persists regarding the potential detrimental metabolic effects and side effects of diuretic agents. Within the risk-benefit debates about diuretic therapy is a second dialogue regarding the best thiazide or thiazidelike agent to prescribe. Proponents of chlorthalidone emphasize the demonstrated reductions in cardiovascular events reported from multiple classic trials and its longer half-life, whereas opponents point to its limited availability in low-dose forms and comparable favorable results from hydrochlorothiazide-based therapy to discredit claims of superiority. This review presents the data available on both sides of this issue to help the reader decide which claims are most valid, and offers recommendations for treatment.
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors